Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses
about
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of ageVery early combination antiretroviral therapy in infants: prospects for cureProgrammed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usageHuman immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babyLongitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection.Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature reviewAutologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART.Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.Absence of detectable HIV-1 viremia after treatment cessation in an infant.HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentHuman immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero."Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescentsComprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.HIV-1 seronegativity in a child with proved perinatal HIV infection on HAARTCross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans.Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartmentImmunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapyReactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis.Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in InfantsModified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding.Recommendations in pediatric antiretroviral therapy.Advances and hope for perinatal HIV remission and cure in children and adolescents.Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loadsImmunology of pediatric HIV infectionPediatric HIV infection: the state of antiretroviral therapy.Impact of the DNA extraction method on 2-LTR DNA circle recovery from HIV-1 infected cellsTiming of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.False negative HIV antibody test in HIV infected children who receive early antiretroviral treatment in a resource-limited setting.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.
P2860
Q24202004-E5DFFF49-0640-4ED4-B7D0-805257891A30Q26830063-E2D94127-0115-4BDF-A235-591B6A1C81FAQ28749172-F5A30C32-8099-4277-A2FA-7733EFB51F05Q30422793-A7EF10FA-44C1-4E3E-9746-865BB6A53848Q33557037-26F7E008-01A4-4B1F-956F-23E9D753D1F3Q33843438-19BF736B-319B-472D-AC6C-272A74091A3BQ33847697-C4FAA0CC-17D4-425E-BDE2-39534D6338B6Q34003099-A87F56DF-40AC-489A-BE32-3D74A3E201F1Q34103202-D411EA15-7606-4618-BC91-3DE839492059Q34285730-E7DA7BA9-C74B-49F6-AE1B-AFFAD6A35256Q34379777-A900F431-9D81-4B8D-B812-2F2A80503275Q34430211-D8FDB78D-25B5-43E7-BD3F-39D15F105202Q34461381-16CC1227-E483-46B8-BAEF-76F99DB3DE06Q34520218-48209AFC-00CA-4062-97AD-0365BF29AE69Q34716901-A3188A52-CE74-44B1-B980-6CE99E6E58BCQ34720281-BB2D1750-3FAD-450C-9D2C-298BADBDF849Q34760550-A923BD62-8A77-42FA-84AA-FB0A9C1C7043Q35072975-5B19A275-4CC3-436A-84B5-F1B27A4BBF6DQ35149075-F69328E2-24AD-484D-BEC0-ACBCF49F1C32Q35531964-E7ACF2FE-CC0B-4149-9D93-43DD22F593E1Q35551374-67FF3A49-638D-4145-8001-97C52BBA6FC9Q35895763-11FD44C5-B834-47D6-9D38-DA21ABE32F1FQ35923609-557A57E9-7238-4479-80E5-44FDD4BEA805Q35929985-1FABC7FD-1F7D-4788-BE8A-D526D4665892Q35962423-2DEEE2D7-34E8-4866-AAE8-37787C48769AQ35996827-0880F499-7601-4399-B0D4-3DC05F3B0481Q36055506-4884FD1E-D954-4730-9211-7E8AA818C878Q36206191-D8CA38F5-2296-4865-AF2A-07AE55DCF186Q36274030-56111085-D9A7-4A91-9194-15A0EE344F10Q36335386-2031BFD0-F5BB-4D7A-B547-F039CF69E584Q36719674-D0D6423D-7755-46CC-A714-40C6FCA31535Q36737063-EFDE71AC-5002-40E5-98AF-4013FBB7BE44Q36943833-4F63AC4E-D86A-4224-9E7B-2571EFFE5EDBQ37080573-E1FC1D6D-82F0-4692-8207-68CC94864DE2Q37124873-D4F4205B-35A2-4432-9E29-1A8C2399EF83Q37141282-6C477EB9-ACA2-4D18-9088-92B4079D1540Q37194666-63AD5867-C7C1-437F-A044-C0A9A3B01455Q37271461-0BD6DA18-7CC5-43C8-8E70-10BE52AB30EDQ37482026-E264DF90-2CED-4615-8A5F-0ADB88CEC4CCQ38036063-467189F9-D342-4BCF-8C74-F3C5B8D256D3
P2860
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Early therapy of vertical huma ...... IV-1-specific immune responses
@ast
Early therapy of vertical huma ...... IV-1-specific immune responses
@en
type
label
Early therapy of vertical huma ...... IV-1-specific immune responses
@ast
Early therapy of vertical huma ...... IV-1-specific immune responses
@en
prefLabel
Early therapy of vertical huma ...... IV-1-specific immune responses
@ast
Early therapy of vertical huma ...... IV-1-specific immune responses
@en
P2093
P2860
P1433
P1476
Early therapy of vertical huma ...... IV-1-specific immune responses
@en
P2093
J L Sullivan
K Luzuriaga
M Catalina
M Stevenson
P2860
P304
P356
10.1128/JVI.74.15.6984-6991.2000
P577
2000-08-01T00:00:00Z